Your browser doesn't support javascript.
loading
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Chau, Ian; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frédéric; Kudo, Masatoshi; Pfiffer, Tulio; Hatano, Etsuro; Chung, Hyun Cheol; Kopeckova, Katerina; Phelip, Jean-Marc; Brandi, Giovanni; Ohkawa, Shinichi; Li, Chung-Pin; Okusaka, Takuji; Hsu, Yanzhi; Abada, Paolo B; Zhu, Andrew X.
Afiliação
  • Chau I; Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, UK. Ian.Chau@rmh.nhs.uk.
  • Park JO; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710, Korea.
  • Ryoo BY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.
  • Yen CJ; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan.
  • Poon R; Departmentof Surgery, The University of Hong Kong, Pokfulam, Hong Kong.
  • Pastorelli D; Department of Oncology, Santa Maria del Prato Hospital, Feltre (Belluno), 32032, Italy.
  • Blanc JF; Department of Hepato-Gastroenterology and Medical Oncology, CHU de Bordeaux, Hôpital Haut-Lévêque, 33604, Pessac, France.
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, 589-8511, Japan.
  • Pfiffer T; Department of Medical Oncology, Instituto do Câncer do Estado de São Paulo, São Paulo, 01246-000, Brazil.
  • Hatano E; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
  • Chung HC; Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, 03722, Korea.
  • Kopeckova K; Department of Oncology, University Hospital Motol, 2nd Faculty of Medicine of Charles University, 150 00, Praha, Czech Republic.
  • Phelip JM; Department of Gastroenterology and Digestive Oncology, University Hospital of St Etienne, 42100, Saint Etienne, France.
  • Brandi G; Department of Experimental, Diagnostic and Specialty Medicine, University Hospital S. Orsola, 40138, Bologna, Italy.
  • Ohkawa S; Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, 241-0815, Japan.
  • Li CP; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, 112, Taiwan.
  • Okusaka T; National Yang-Ming University School of Medicine, Taipei, 112, Taiwan.
  • Hsu Y; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Abada PB; Eli Lilly and Company, New York, NY, 10016, USA.
  • Zhu AX; Eli Lilly and Company, Indianapolis, IN, 46285, USA.
Br J Cancer ; 119(1): 19-26, 2018 07.
Article em En | MEDLINE | ID: mdl-29808014
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alfa-Fetoproteínas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alfa-Fetoproteínas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article